MABVAX THERAPEUTICS HLDGS IN - COM NEW (MBVX) Institutional Ownership

CUSIP: 55414P504

13F Institutional Holders and Ownership History from Q3 2016 to Q1 2018

Type / Class
Equity / COM NEW
Symbol
MBVX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 55414P504?
CUSIP 55414P504 identifies MBVX - MABVAX THERAPEUTICS HLDGS IN - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of MABVAX THERAPEUTICS HLDGS IN - COM NEW (MBVX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2018 Q1 0 $0 -$2,289,000 0
2017 Q4 3,269,468 $2,289,000 +$436,199 $0.70 10
2017 Q3 2,647,374 $1,722,000 +$1,665,641 $0.65 9
2017 Q2 85,848 $119,000 +$15,254 $1.39 6
2017 Q1 62,038 $141,000 -$65,290 $2.27 4
2016 Q4 83,189 $281,000 -$40,770 $3.38 4
2016 Q3 95,639 $405,000 +$405,000 $4.23 4